Skip to Main Content

Paper Details

Targeted Deep Sequencing of Bladder Tumors Reveals Novel Associations between Cancer Gene Mutations and Mutational Signatures with Major Risk Factors.
Clin Cancer Res
12
2021
APOBEC, APOBEC-Signature13, APOBEC-Signature13 mutations, APOBEC-Signature2 mutations, Bladder Tumors, Cancer, Cancer Gene, ERCC2, ERCC2-Signature, ERCC2-Signature mutations, KDM6A, bladder cancer, bladder tumors, cancer, formalin, muscle-invasive bladder cancer, mutated genes, non-muscle-invasive bladder cancer
Author NameAffiliation
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Michael DeanNational Cancer Institute, National Institutes of Health
Michael DeanNational Cancer Institute, Leidos Biomedical Research Inc.
  • 1 - 4

Datasets

Release 1.2